Media Centre

The Pneumococcal AMC: Ready to Save Lives
12 June 2009
Pneumococcal disease is one of the biggest vaccine preventable killers of children today and most of these deaths occur in the developing world where no optimal vaccine is yet available. But now, thanks to the Pneumococcal Advance Market Commitment (AMC) that's all about to change.
Watch the video

Update: GAVI Partners Fulfil Promise to Fight Pneumococcal Disease
12 June 2009
The GAVI Alliance partners, the World Bank, WHO and UNICEF, and five national governments and the Bill & Melinda Gates Foundation today formally kicked-off the first-ever Advance Market Commitment (AMC) designed to accelerate access to vaccines against pneumococcal disease.
Press release

Update: GAVI Alliance welcomes World Bank decision on AMC initiative
6 April 2009
GAVI Alliance Chief Executive Officer Dr. Julian Lob-Levyt welcomes the April 3rd decision by the World Bank to provide a financial platform for the AMC.
Press release

Update from Donor Committee: Pilot Advance Market Commitment for Pneumococcal Disease
June 2008
The leading cause of death among children under five, pneumococcal disease causes pneumonia, meningitis and sepsis.
Press release

Update from Donor Committee: Work is underway to determine the optimal terms for a pilot AMC.
May 2008
Pneumococcal diseases kill more than 1.6 million people worldwide each year, including at least 800,000 children. The most effective way to prevent these deaths is to ensure children have access to effective, safe and affordable vaccines.
Press release

Fact Sheets

AMC Fact Sheet
(PDF, 562Kb)

AMC FAQs
(PDF, 348Kb)

 

Resources

Learn more about the impact of pneumococcal diseases Click here